SI9720026A - Arilamino kondenzirani piridini in pirimidini - Google Patents

Info

Publication number

SI9720026A

SI9720026A SI9720026A SI9720026A SI9720026A SI 9720026 A SI9720026 A SI 9720026A SI 9720026 A SI9720026 A SI 9720026A SI 9720026 A SI9720026 A SI 9720026A SI 9720026 A SI9720026 A SI 9720026A

Authority

SI

Slovenia

Prior art keywords

alkyl

cor

methyl

cycloalkyl

occurrence

Prior art date

1996-03-27

Links

• Espacenet
• Global Dossier
• Discuss

• 150000003230 pyrimidines Chemical class 0.000 title claims description 12
• 150000003222 pyridines Chemical class 0.000 title description 6
• 125000001769 aryl amino group Chemical group 0.000 title 1
• 208000019901 Anxiety disease Diseases 0.000 claims abstract description 11
• 230000036506 anxiety Effects 0.000 claims abstract description 11
• 239000005557 antagonist Substances 0.000 claims abstract description 10
• 150000001875 compounds Chemical class 0.000 claims description 193
• -1 C r C 4 haloalkyl Chemical group 0.000 claims description 159
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 84
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 80
• 125000005843 halogen group Chemical group 0.000 claims description 74
• 229910052739 hydrogen Inorganic materials 0.000 claims description 74
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 66
• 125000001072 heteroaryl group Chemical group 0.000 claims description 66
• 125000003118 aryl group Chemical group 0.000 claims description 65
• 229910052799 carbon Inorganic materials 0.000 claims description 65
• 125000000217 alkyl group Chemical group 0.000 claims description 56
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 55
• 125000001424 substituent group Chemical group 0.000 claims description 47
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 45
• 229910052757 nitrogen Inorganic materials 0.000 claims description 40
• 238000000034 method Methods 0.000 claims description 39
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 38
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 33
• 239000002904 solvent Substances 0.000 claims description 33
• XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims description 32
• 125000003831 tetrazolyl group Chemical group 0.000 claims description 29
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 27
• 229910052727 yttrium Inorganic materials 0.000 claims description 24
• 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 23
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 22
• 125000003226 pyrazolyl group Chemical group 0.000 claims description 19
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 18
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 18
• 125000004076 pyridyl group Chemical group 0.000 claims description 18
• 150000003839 salts Chemical class 0.000 claims description 18
• 125000001425 triazolyl group Chemical group 0.000 claims description 18
• 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 17
• 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 17
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 17
• 125000000623 heterocyclic group Chemical group 0.000 claims description 17
• 229920006395 saturated elastomer Polymers 0.000 claims description 17
• NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 claims description 16
• 125000005865 C2-C10alkynyl group Chemical group 0.000 claims description 16
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 16
• 125000000842 isoxazolyl group Chemical group 0.000 claims description 15
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
• 125000001624 naphthyl group Chemical group 0.000 claims description 15
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 15
• 125000000714 pyrimidinyl group Chemical group 0.000 claims description 15
• 125000000168 pyrrolyl group Chemical group 0.000 claims description 15
• 125000000335 thiazolyl group Chemical group 0.000 claims description 15
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 14
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 14
• 125000001309 chloro group Chemical group Cl* 0.000 claims description 14
• 125000002883 imidazolyl group Chemical group 0.000 claims description 14
• 125000001041 indolyl group Chemical group 0.000 claims description 14
• 125000001544 thienyl group Chemical group 0.000 claims description 14
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 13
• 125000002971 oxazolyl group Chemical group 0.000 claims description 13
• 229910052760 oxygen Inorganic materials 0.000 claims description 13
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 13
• 125000002541 furyl group Chemical group 0.000 claims description 12
• 125000001188 haloalkyl group Chemical group 0.000 claims description 12
• 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 12
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 11
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 11
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 11
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
• 239000000651 prodrug Substances 0.000 claims description 11
• 229940002612 prodrug Drugs 0.000 claims description 11
• 125000004306 triazinyl group Chemical group 0.000 claims description 11
• 239000003814 drug Substances 0.000 claims description 10
• 229960004979 fampridine Drugs 0.000 claims description 10
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 9
• 241000124008 Mammalia Species 0.000 claims description 9
• 125000005233 alkylalcohol group Chemical group 0.000 claims description 9
• 239000002769 corticotropin releasing factor antagonist Substances 0.000 claims description 9
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
• BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 9
• 125000006219 1-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims description 8
• 150000001412 amines Chemical class 0.000 claims description 8
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 8
• 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 7
• 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 7
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 7
• 229940122010 Corticotropin releasing factor antagonist Drugs 0.000 claims description 7
• 229940079593 drug Drugs 0.000 claims description 7
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims description 7
• 229910052717 sulfur Inorganic materials 0.000 claims description 7
• 239000003638 chemical reducing agent Substances 0.000 claims description 6
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 6
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 6
• 239000008194 pharmaceutical composition Substances 0.000 claims description 6
• 208000024891 symptom Diseases 0.000 claims description 6
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 5
• 150000008064 anhydrides Chemical class 0.000 claims description 5
• 150000004982 aromatic amines Chemical class 0.000 claims description 5
• 125000001246 bromo group Chemical group Br* 0.000 claims description 5
• 229910052801 chlorine Inorganic materials 0.000 claims description 5
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 5
• 238000002360 preparation method Methods 0.000 claims description 5
• 208000030814 Eating disease Diseases 0.000 claims description 4
• 208000019454 Feeding and Eating disease Diseases 0.000 claims description 4
• 206010033799 Paralysis Diseases 0.000 claims description 4
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 4
• 125000000304 alkynyl group Chemical group 0.000 claims description 4
• 235000014632 disordered eating Nutrition 0.000 claims description 4
• 230000004970 emotional disturbance Effects 0.000 claims description 4
• VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims description 4
• 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 3
• 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 3
• 208000024827 Alzheimer disease Diseases 0.000 claims description 3
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 3
• 125000003342 alkenyl group Chemical group 0.000 claims description 3
• 208000028173 post-traumatic stress disease Diseases 0.000 claims description 3
• DQVBPXWHSGPGGF-UHFFFAOYSA-N 1-[3-bromo-4-[[5-methyl-3-(3-methylhexyl)triazolo[4,5-d]pyrimidin-7-yl]amino]phenyl]ethanone Chemical compound N1=C(C)N=C2N(CCC(C)CCC)N=NC2=C1NC1=CC=C(C(C)=O)C=C1Br DQVBPXWHSGPGGF-UHFFFAOYSA-N 0.000 claims description 2
• ABTLZAVJDRUDNG-UHFFFAOYSA-N 4,6-dihydroxy-5-nitropyrimidine Chemical compound OC=1N=CNC(=O)C=1[N+]([O-])=O ABTLZAVJDRUDNG-UHFFFAOYSA-N 0.000 claims description 2
• 208000018522 Gastrointestinal disease Diseases 0.000 claims description 2
• 206010013663 drug dependence Diseases 0.000 claims description 2
• 230000035558 fertility Effects 0.000 claims description 2
• 230000008629 immune suppression Effects 0.000 claims description 2
• 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 2
• 208000027866 inflammatory disease Diseases 0.000 claims description 2
• 208000002551 irritable bowel syndrome Diseases 0.000 claims description 2
• OZRWLDWLXLQGTA-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-3-[1-(dimethylamino)pentan-2-yl]-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(C(CN(C)C)CCC)N=NC2=C1NC1=CC=C(C(C)C)C=C1Br OZRWLDWLXLQGTA-UHFFFAOYSA-N 0.000 claims description 2
• JYLSBRVMLQBLMF-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-9-heptan-4-yl-2-methylpurin-6-amine Chemical compound N1=C(C)N=C2N(C(CCC)CCC)C=NC2=C1NC1=CC=C(C(C)C)C=C1Br JYLSBRVMLQBLMF-UHFFFAOYSA-N 0.000 claims description 2
• 230000008569 process Effects 0.000 claims description 2
• SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 2
• 208000011117 substance-related disease Diseases 0.000 claims description 2
• 125000001153 fluoro group Chemical group F* 0.000 claims 3
• 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
• 235000019000 fluorine Nutrition 0.000 claims 2
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims 2
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
• FHARGMSSJPHLMO-UHFFFAOYSA-N 2-(2h-pyrimidin-1-yl)acetic acid Chemical compound OC(=O)CN1CN=CC=C1 FHARGMSSJPHLMO-UHFFFAOYSA-N 0.000 claims 1
• WIBMRIKMUDTAIE-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=NNN=C12 WIBMRIKMUDTAIE-UHFFFAOYSA-N 0.000 claims 1
• ATZKRIDPBKBWQF-UHFFFAOYSA-N 3-(2-methoxyethyl)-5-methyl-n-(2,4,6-trimethylphenyl)triazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCOC)N=NC2=C1NC1=C(C)C=C(C)C=C1C ATZKRIDPBKBWQF-UHFFFAOYSA-N 0.000 claims 1
• 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 1
• 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 1
• 206010029216 Nervousness Diseases 0.000 claims 1
• 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
• 208000029650 alcohol withdrawal Diseases 0.000 claims 1
• 208000022531 anorexia Diseases 0.000 claims 1
• 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
• 206010061428 decreased appetite Diseases 0.000 claims 1
• 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
• 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• QZSNBXBYBOVBMW-UHFFFAOYSA-N n-(2-bromo-4,6-dimethoxyphenyl)-1-heptan-4-yl-6-methyltriazolo[4,5-c]pyridin-4-amine Chemical compound N1=C(C)C=C2N(C(CCC)CCC)N=NC2=C1NC1=C(Br)C=C(OC)C=C1OC QZSNBXBYBOVBMW-UHFFFAOYSA-N 0.000 claims 1
• LTWYQWWAOJZQCO-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-3-(2-methoxyethyl)-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCOC)N=NC2=C1NC1=CC=C(C(C)C)C=C1Br LTWYQWWAOJZQCO-UHFFFAOYSA-N 0.000 claims 1
• LQTULWFILCBYJG-IBGZPJMESA-N n-(2-bromo-4-propan-2-ylphenyl)-3-[(2s)-1-methoxy-3-phenylpropan-2-yl]-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound C([C@@H](COC)N1C2=NC(C)=NC(NC=3C(=CC(=CC=3)C(C)C)Br)=C2N=N1)C1=CC=CC=C1 LQTULWFILCBYJG-IBGZPJMESA-N 0.000 claims 1
• YQQLXLJEXNRAEH-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-3-butyl-n-ethyl-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCCC)N=NC2=C1N(CC)C1=CC=C(C(C)C)C=C1Br YQQLXLJEXNRAEH-UHFFFAOYSA-N 0.000 claims 1
• PCPVTEGZDWLXBQ-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-6-methyl-1-pentan-3-yltriazolo[4,5-c]pyridin-4-amine Chemical compound N1=C(C)C=C2N(C(CC)CC)N=NC2=C1NC1=CC=C(C(C)C)C=C1Br PCPVTEGZDWLXBQ-UHFFFAOYSA-N 0.000 claims 1
• JKZPOGPBWILNOP-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-n-ethyl-5-methyl-3-propyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCC)N=NC2=C1N(CC)C1=CC=C(C(C)C)C=C1Br JKZPOGPBWILNOP-UHFFFAOYSA-N 0.000 claims 1
• MQYAUMADWUJPIZ-UHFFFAOYSA-N n-(4-bromo-2-methylphenyl)-3-heptan-4-yl-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(C(CCC)CCC)N=NC2=C1NC1=CC=C(Br)C=C1C MQYAUMADWUJPIZ-UHFFFAOYSA-N 0.000 claims 1
• JTBLVQDUNOACST-UHFFFAOYSA-N n-ethyl-3-(2-methoxyethyl)-5-methyl-n-(2,4,6-trimethylphenyl)triazolo[4,5-d]pyrimidin-7-amine Chemical compound N=1C(C)=NC=2N(CCOC)N=NC=2C=1N(CC)C1=C(C)C=C(C)C=C1C JTBLVQDUNOACST-UHFFFAOYSA-N 0.000 claims 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
• 239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract description 31
• 208000012902 Nervous system disease Diseases 0.000 abstract description 4
• 208000025966 Neurological disease Diseases 0.000 abstract description 4
• 208000020016 psychiatric disease Diseases 0.000 abstract description 4
• 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 abstract description 3
• 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 abstract 2
• QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 381
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 348
• 239000000047 product Substances 0.000 description 182
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 174
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 172
• 239000007787 solid Substances 0.000 description 139
• 235000019439 ethyl acetate Nutrition 0.000 description 133
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 112
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 102
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 94
• 238000006243 chemical reaction Methods 0.000 description 93
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 84
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 71
• 238000000921 elemental analysis Methods 0.000 description 70
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 63
• 239000000203 mixture Substances 0.000 description 62
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 60
• 239000000741 silica gel Substances 0.000 description 55
• 229910002027 silica gel Inorganic materials 0.000 description 55
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 51
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 45
• 239000000460 chlorine Substances 0.000 description 43
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
• 238000004587 chromatography analysis Methods 0.000 description 40
• 239000000284 extract Substances 0.000 description 38
• 239000003921 oil Substances 0.000 description 38
• 235000019198 oils Nutrition 0.000 description 38
• 238000010992 reflux Methods 0.000 description 34
• 239000000243 solution Substances 0.000 description 34
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
• 239000011541 reaction mixture Substances 0.000 description 30
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
• 239000012267 brine Substances 0.000 description 29
• 239000002585 base Chemical class 0.000 description 28
• 102100021752 Corticoliberin Human genes 0.000 description 27
• 239000012264 purified product Substances 0.000 description 27
• 229910000104 sodium hydride Inorganic materials 0.000 description 27
• 101710113174 Corticoliberin Proteins 0.000 description 26
• 239000012044 organic layer Substances 0.000 description 25
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
• 238000005481 NMR spectroscopy Methods 0.000 description 20
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 20
• 239000012312 sodium hydride Substances 0.000 description 20
• OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 19
• 239000012230 colorless oil Substances 0.000 description 17
• 239000010410 layer Substances 0.000 description 16
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 229960000583 acetic acid Drugs 0.000 description 15
• 239000002253 acid Substances 0.000 description 15
• 238000010790 dilution Methods 0.000 description 15
• 239000012895 dilution Substances 0.000 description 15
• 238000003818 flash chromatography Methods 0.000 description 15
• 108090000765 processed proteins & peptides Proteins 0.000 description 15
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 14
• 238000003756 stirring Methods 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• 229940024606 amino acid Drugs 0.000 description 13
• 150000001413 amino acids Chemical class 0.000 description 13
• 238000000605 extraction Methods 0.000 description 13
• 239000000543 intermediate Substances 0.000 description 13
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
• 239000000706 filtrate Substances 0.000 description 12
• 239000012442 inert solvent Substances 0.000 description 12
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 11
• 229910052783 alkali metal Inorganic materials 0.000 description 11
• 230000000694 effects Effects 0.000 description 11
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
• 239000004480 active ingredient Substances 0.000 description 10
• 229910000102 alkali metal hydride Inorganic materials 0.000 description 10
• 150000008046 alkali metal hydrides Chemical class 0.000 description 10
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 9
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
• 238000007363 ring formation reaction Methods 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
• CLJMMQGDJNYDER-UHFFFAOYSA-N heptan-4-amine Chemical compound CCCC(N)CCC CLJMMQGDJNYDER-UHFFFAOYSA-N 0.000 description 8
• AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-Me3C6H3 Natural products CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 7
• 101800000414 Corticotropin Proteins 0.000 description 7
• 210000004027 cell Anatomy 0.000 description 7
• 239000003795 chemical substances by application Substances 0.000 description 7
• IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 7
• 229960000258 corticotropin Drugs 0.000 description 7
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 7
• OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 7
• 235000010288 sodium nitrite Nutrition 0.000 description 7
• WEMDUNBELVTSRP-UHFFFAOYSA-N 2-bromo-4-propan-2-ylaniline Chemical compound CC(C)C1=CC=C(N)C(Br)=C1 WEMDUNBELVTSRP-UHFFFAOYSA-N 0.000 description 6
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• 102400000739 Corticotropin Human genes 0.000 description 6
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
• 150000001340 alkali metals Chemical class 0.000 description 6
• 150000001408 amides Chemical class 0.000 description 6
• 229940049706 benzodiazepine Drugs 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 239000002024 ethyl acetate extract Substances 0.000 description 6
• HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 6
• 229910052742 iron Inorganic materials 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical class [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 6
• WERYXYBDKMZEQL-UHFFFAOYSA-N 1,4-butanediol Substances OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 5
• HDXNPIRMUMFLIC-UHFFFAOYSA-N 2-bromo-4,6-dimethoxyaniline Chemical compound COC1=CC(Br)=C(N)C(OC)=C1 HDXNPIRMUMFLIC-UHFFFAOYSA-N 0.000 description 5
• LXOGQFQXRSVZRP-UHFFFAOYSA-N 4-chloro-6-methyl-3-nitro-1h-pyridin-2-one Chemical compound CC1=CC(Cl)=C([N+]([O-])=O)C(O)=N1 LXOGQFQXRSVZRP-UHFFFAOYSA-N 0.000 description 5
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
• 230000009471 action Effects 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 230000003542 behavioural effect Effects 0.000 description 5
• 239000002775 capsule Substances 0.000 description 5
• 239000006071 cream Substances 0.000 description 5
• 239000013078 crystal Substances 0.000 description 5
• 150000004292 cyclic ethers Chemical class 0.000 description 5
• 238000006193 diazotization reaction Methods 0.000 description 5
• 208000035475 disorder Diseases 0.000 description 5
• SRMHHEPXZLWKOK-UHFFFAOYSA-N heptan-3-amine Chemical compound CCCCC(N)CC SRMHHEPXZLWKOK-UHFFFAOYSA-N 0.000 description 5
• 230000005764 inhibitory process Effects 0.000 description 5
• 239000012299 nitrogen atmosphere Substances 0.000 description 5
• 239000003960 organic solvent Substances 0.000 description 5
• 150000003141 primary amines Chemical class 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 239000003826 tablet Substances 0.000 description 5
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
• QAFODUGVXFNLBE-UHFFFAOYSA-N 1-methoxybutan-2-amine Chemical compound CCC(N)COC QAFODUGVXFNLBE-UHFFFAOYSA-N 0.000 description 4
• SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 4
• VHHUWUXXXYAXQA-UHFFFAOYSA-N 2-(tritylamino)propane-1,3-diol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(NC(CO)CO)C1=CC=CC=C1 VHHUWUXXXYAXQA-UHFFFAOYSA-N 0.000 description 4
• IHGSJUGRPUIDRO-UHFFFAOYSA-N 2-chloro-4,6-dimethoxyaniline Chemical compound COC1=CC(Cl)=C(N)C(OC)=C1 IHGSJUGRPUIDRO-UHFFFAOYSA-N 0.000 description 4
• 108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 description 4
• DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
• OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 230000000949 anxiolytic effect Effects 0.000 description 4
• 238000009835 boiling Methods 0.000 description 4
• 210000004556 brain Anatomy 0.000 description 4
• 239000011449 brick Substances 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 238000001816 cooling Methods 0.000 description 4
• PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
• 201000010099 disease Diseases 0.000 description 4
• 150000003948 formamides Chemical class 0.000 description 4
• 239000007903 gelatin capsule Substances 0.000 description 4
• HQLZFBUAULNEGP-UHFFFAOYSA-N hexan-3-amine Chemical compound CCCC(N)CC HQLZFBUAULNEGP-UHFFFAOYSA-N 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
• 235000019341 magnesium sulphate Nutrition 0.000 description 4
• 150000002828 nitro derivatives Chemical class 0.000 description 4
• 239000008188 pellet Substances 0.000 description 4
• PQPFFKCJENSZKL-UHFFFAOYSA-N pentan-3-amine Chemical compound CCC(N)CC PQPFFKCJENSZKL-UHFFFAOYSA-N 0.000 description 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
• 102000004196 processed proteins & peptides Human genes 0.000 description 4
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 239000011734 sodium Substances 0.000 description 4
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
• GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 4
• UXTMZEUXBGJMCH-UHFFFAOYSA-N 1,3-dimethoxypropan-2-amine;hydrochloride Chemical compound Cl.COCC(N)COC UXTMZEUXBGJMCH-UHFFFAOYSA-N 0.000 description 3
• MVBJMNVQPORRMS-UHFFFAOYSA-N 2-azido-1-methoxybutane Chemical compound COCC(CC)N=[N+]=[N-] MVBJMNVQPORRMS-UHFFFAOYSA-N 0.000 description 3
• LKAQFOKMMXWRRQ-UHFFFAOYSA-N 2-chloro-4,6-dimethylaniline Chemical compound CC1=CC(C)=C(N)C(Cl)=C1 LKAQFOKMMXWRRQ-UHFFFAOYSA-N 0.000 description 3
• GIIGHSIIKVOWKZ-UHFFFAOYSA-N 2h-triazolo[4,5-d]pyrimidine Chemical class N1=CN=CC2=NNN=C21 GIIGHSIIKVOWKZ-UHFFFAOYSA-N 0.000 description 3
• OPXGPTXSLFZVCA-UHFFFAOYSA-N 4,6-dichloro-2-methyl-5-nitropyrimidine Chemical compound CC1=NC(Cl)=C([N+]([O-])=O)C(Cl)=N1 OPXGPTXSLFZVCA-UHFFFAOYSA-N 0.000 description 3
• QIKWTNPFTOEELW-UHFFFAOYSA-N 4-hydroxy-6-methyl-3-nitro-1h-pyridin-2-one Chemical compound CC1=CC(=O)C([N+]([O-])=O)=C(O)N1 QIKWTNPFTOEELW-UHFFFAOYSA-N 0.000 description 3
• HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical class NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 3
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
• 102100027467 Pro-opiomelanocortin Human genes 0.000 description 3
• 229910004298 SiO 2 Inorganic materials 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 125000003545 alkoxy group Chemical group 0.000 description 3
• 125000006242 amine protecting group Chemical class 0.000 description 3
• 235000011114 ammonium hydroxide Nutrition 0.000 description 3
• 239000002249 anxiolytic agent Substances 0.000 description 3
• 229940005530 anxiolytics Drugs 0.000 description 3
• 229940009098 aspartate Drugs 0.000 description 3
• 125000004429 atom Chemical group 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 239000003054 catalyst Substances 0.000 description 3
• 210000003169 central nervous system Anatomy 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 239000012043 crude product Substances 0.000 description 3
• 239000003480 eluent Substances 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 239000011737 fluorine Substances 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 150000008282 halocarbons Chemical class 0.000 description 3
• 229910052736 halogen Inorganic materials 0.000 description 3
• 150000002367 halogens Chemical class 0.000 description 3
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 235000019359 magnesium stearate Nutrition 0.000 description 3
• 238000002844 melting Methods 0.000 description 3
• 230000008018 melting Effects 0.000 description 3
• 238000003752 polymerase chain reaction Methods 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 238000000159 protein binding assay Methods 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 238000010898 silica gel chromatography Methods 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 125000003396 thiol group Chemical class [H]S* 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical compound BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 description 3
• JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 3
• ASMVJBACZFHISI-UHFFFAOYSA-N 1-(4-amino-3-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N)C(Br)=C1 ASMVJBACZFHISI-UHFFFAOYSA-N 0.000 description 2
• PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 2
• 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
• KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 2
• QKRJIXSZTKOFTD-UHFFFAOYSA-N 2-bromo-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1Br QKRJIXSZTKOFTD-UHFFFAOYSA-N 0.000 description 2
• GAUUADFRRZLPJT-UHFFFAOYSA-N 2-chloro-n-heptan-4-yl-6-methyl-3-nitropyridin-4-amine Chemical compound CCCC(CCC)NC1=CC(C)=NC(Cl)=C1[N+]([O-])=O GAUUADFRRZLPJT-UHFFFAOYSA-N 0.000 description 2
• ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
• 229940093475 2-ethoxyethanol Drugs 0.000 description 2
• ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 2
• GLICOKXHOMPORJ-UHFFFAOYSA-N 2-n-(2-bromo-4-propan-2-ylphenyl)-2-n-heptan-4-yl-6-methyl-3-nitropyridine-2,4-diamine Chemical compound N=1C(C)=CC(N)=C([N+]([O-])=O)C=1N(C(CCC)CCC)C1=CC=C(C(C)C)C=C1Br GLICOKXHOMPORJ-UHFFFAOYSA-N 0.000 description 2
• BHTKBUHNIZPKSG-UHFFFAOYSA-N 3,4-diamino-1h-pyridin-2-one Chemical compound NC=1C=CNC(=O)C=1N BHTKBUHNIZPKSG-UHFFFAOYSA-N 0.000 description 2
• NONAPDJJAFAIKB-UHFFFAOYSA-N 3-(tritylamino)oxolan-2-one Chemical compound O=C1OCCC1NC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 NONAPDJJAFAIKB-UHFFFAOYSA-N 0.000 description 2
• DUFGYCAXVIUXIP-UHFFFAOYSA-N 4,6-dihydroxypyrimidine Chemical class OC1=CC(O)=NC=N1 DUFGYCAXVIUXIP-UHFFFAOYSA-N 0.000 description 2
• SRJMUQXQOVOHAH-UHFFFAOYSA-N 4-(heptan-4-ylamino)-6-methyl-3-nitro-1h-pyridin-2-one Chemical compound CCCC(CCC)NC=1C=C(C)NC(=O)C=1[N+]([O-])=O SRJMUQXQOVOHAH-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical class C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 2
• QGLAYJCJLHNIGJ-UHFFFAOYSA-N 4-bromo-2,6-dimethylaniline Chemical compound CC1=CC(Br)=CC(C)=C1N QGLAYJCJLHNIGJ-UHFFFAOYSA-N 0.000 description 2
• INJVHFYRJIWNOT-VIFPVBQESA-N 4-chloro-1-[(2s)-1,4-dimethoxybutan-2-yl]-6-methyltriazolo[4,5-c]pyridine Chemical compound N1=C(C)C=C2N([C@H](COC)CCOC)N=NC2=C1Cl INJVHFYRJIWNOT-VIFPVBQESA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 102000009346 Adenosine receptors Human genes 0.000 description 2
• 108050000203 Adenosine receptors Proteins 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• OPHQZBRUKZVGDD-UHFFFAOYSA-N C(CCC)NC1=C2NN=NC2=NC(=N1)C Chemical compound C(CCC)NC1=C2NN=NC2=NC(=N1)C OPHQZBRUKZVGDD-UHFFFAOYSA-N 0.000 description 2
• 208000027534 Emotional disease Diseases 0.000 description 2
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
• 108010069820 Pro-Opiomelanocortin Proteins 0.000 description 2
• 239000000683 Pro-Opiomelanocortin Substances 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 229920002472 Starch Chemical class 0.000 description 2
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 102000030621 adenylate cyclase Human genes 0.000 description 2
• 108060000200 adenylate cyclase Proteins 0.000 description 2
• 239000003513 alkali Substances 0.000 description 2
• 230000029936 alkylation Effects 0.000 description 2
• 238000005804 alkylation reaction Methods 0.000 description 2
• 239000000908 ammonium hydroxide Substances 0.000 description 2
• 150000003863 ammonium salts Chemical class 0.000 description 2
• 230000000338 anxiogenic effect Effects 0.000 description 2
• 125000005228 aryl sulfonate group Chemical group 0.000 description 2
• 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 2
• 238000004166 bioassay Methods 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 239000001913 cellulose Chemical class 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Chemical class 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 239000007891 compressed tablet Substances 0.000 description 2
• 239000006184 cosolvent Substances 0.000 description 2
• 239000013058 crude material Substances 0.000 description 2
• 238000002425 crystallisation Methods 0.000 description 2
• 230000008025 crystallization Effects 0.000 description 2
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
• GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 230000002124 endocrine Effects 0.000 description 2
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
• 150000004820 halides Chemical class 0.000 description 2
• 150000002430 hydrocarbons Chemical group 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 229940098779 methanesulfonic acid Drugs 0.000 description 2
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• ALGKROKGDUVGCD-UHFFFAOYSA-N n-(2,4-dibromophenyl)-5-methyl-3-(3-methylhexyl)triazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCC(C)CCC)N=NC2=C1NC1=CC=C(Br)C=C1Br ALGKROKGDUVGCD-UHFFFAOYSA-N 0.000 description 2
• NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 2
• 239000002858 neurotransmitter agent Substances 0.000 description 2
• 229910017604 nitric acid Inorganic materials 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• 239000003182 parenteral nutrition solution Substances 0.000 description 2
• RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 2
• BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 2
• 229910000027 potassium carbonate Inorganic materials 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
• 150000008318 pyrimidones Chemical class 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 238000001953 recrystallisation Methods 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 239000008107 starch Chemical class 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000012258 stirred mixture Substances 0.000 description 2
• 150000003462 sulfoxides Chemical class 0.000 description 2
• 238000013268 sustained release Methods 0.000 description 2
• 239000012730 sustained-release form Substances 0.000 description 2
• 238000000844 transformation Methods 0.000 description 2
• 125000005270 trialkylamine group Chemical group 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
• FTMKEFCCBFJBJI-PPHPATTJSA-N (2s)-1-methoxy-3-phenylpropan-2-amine;hydrochloride Chemical compound Cl.COC[C@@H](N)CC1=CC=CC=C1 FTMKEFCCBFJBJI-PPHPATTJSA-N 0.000 description 1
• CCQGGCWKGAMHGT-KKMMWDRVSA-N (2s)-2-[(4-aminocyclohexyl)amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC1CCC(N)CC1 CCQGGCWKGAMHGT-KKMMWDRVSA-N 0.000 description 1
• VDEMEKSASUGYHM-AXDSSHIGSA-N (2s)-3-phenylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1NCCC1C1=CC=CC=C1 VDEMEKSASUGYHM-AXDSSHIGSA-N 0.000 description 1
• 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• HNXUCZQUSDFOHQ-UHFFFAOYSA-N 1,3-dimethoxy-n-tritylpropan-2-amine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(NC(COC)COC)C1=CC=CC=C1 HNXUCZQUSDFOHQ-UHFFFAOYSA-N 0.000 description 1
• USTORKKPKURXFS-UHFFFAOYSA-N 1,4-dimethoxybutan-2-amine;hydrochloride Chemical compound Cl.COCCC(N)COC USTORKKPKURXFS-UHFFFAOYSA-N 0.000 description 1
• GSTMXKCTNBSBBY-UHFFFAOYSA-N 1-[3-bromo-4-[(5-methyl-3-pentan-3-yltriazolo[4,5-d]pyrimidin-7-yl)amino]phenyl]ethanone Chemical compound N1=C(C)N=C2N(C(CC)CC)N=NC2=C1NC1=CC=C(C(C)=O)C=C1Br GSTMXKCTNBSBBY-UHFFFAOYSA-N 0.000 description 1
• NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
• WVKQECDSKDGQDQ-UHFFFAOYSA-N 1-butyltriazole Chemical compound CCCCN1C=CN=N1 WVKQECDSKDGQDQ-UHFFFAOYSA-N 0.000 description 1
• PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
• CSZZMFWKAQEMPB-UHFFFAOYSA-N 1-methoxybutan-2-ol Chemical compound CCC(O)COC CSZZMFWKAQEMPB-UHFFFAOYSA-N 0.000 description 1
• OXLNZAZNXDMYSE-UHFFFAOYSA-N 1-methoxybutan-2-yl methanesulfonate Chemical compound COCC(CC)OS(C)(=O)=O OXLNZAZNXDMYSE-UHFFFAOYSA-N 0.000 description 1
• QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
• KWVPRPSXBZNOHS-UHFFFAOYSA-N 2,4,6-Trimethylaniline Chemical compound CC1=CC(C)=C(N)C(C)=C1 KWVPRPSXBZNOHS-UHFFFAOYSA-N 0.000 description 1
• MHUDSAALSISURX-UHFFFAOYSA-N 2,4,6-trimethylpyridin-3-amine Chemical compound CC1=CC(C)=C(N)C(C)=N1 MHUDSAALSISURX-UHFFFAOYSA-N 0.000 description 1
• OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
• MTGIKTMXZFIZLS-UHFFFAOYSA-N 2,4-dichloro-6-methyl-3-nitropyridine Chemical compound CC1=CC(Cl)=C([N+]([O-])=O)C(Cl)=N1 MTGIKTMXZFIZLS-UHFFFAOYSA-N 0.000 description 1
• WDFWZGUOMCIPCI-UHFFFAOYSA-N 2,6-dimethyl-4-methylsulfanylaniline Chemical compound CSC1=CC(C)=C(N)C(C)=C1 WDFWZGUOMCIPCI-UHFFFAOYSA-N 0.000 description 1
• VYCNOBNEBXGHKT-UHFFFAOYSA-N 2-(2-methylhydrazinyl)acetic acid Chemical compound CNNCC(O)=O VYCNOBNEBXGHKT-UHFFFAOYSA-N 0.000 description 1
• DXBHVVWSQSOCFB-UHFFFAOYSA-N 2-(2h-pyrimidin-1-yl)ethanol Chemical compound OCCN1CN=CC=C1 DXBHVVWSQSOCFB-UHFFFAOYSA-N 0.000 description 1
• CLTMYNWFSDZKKI-UHFFFAOYSA-N 2-(aminomethyl)benzoic acid Chemical compound NCC1=CC=CC=C1C(O)=O CLTMYNWFSDZKKI-UHFFFAOYSA-N 0.000 description 1
• CQJAWZCYNRBZDL-UHFFFAOYSA-N 2-(methylazaniumyl)butanoate Chemical compound CCC(NC)C(O)=O CQJAWZCYNRBZDL-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• GBUGXAULUBTJFM-UHFFFAOYSA-N 2-[bis(methylamino)amino]acetic acid Chemical compound CNN(NC)CC(O)=O GBUGXAULUBTJFM-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• HHWOYRKNRZSNQE-UHFFFAOYSA-N 2-bromo-4-iodoaniline Chemical compound NC1=CC=C(I)C=C1Br HHWOYRKNRZSNQE-UHFFFAOYSA-N 0.000 description 1
• LIBMRSQEMOANHL-UHFFFAOYSA-N 2-chloro-4-n-(1,4-dimethoxybutan-2-yl)-6-methylpyridine-3,4-diamine Chemical compound COCCC(COC)NC1=CC(C)=NC(Cl)=C1N LIBMRSQEMOANHL-UHFFFAOYSA-N 0.000 description 1
• LIBMRSQEMOANHL-VIFPVBQESA-N 2-chloro-4-n-[(2s)-1,4-dimethoxybutan-2-yl]-6-methylpyridine-3,4-diamine Chemical compound COCC[C@@H](COC)NC1=CC(C)=NC(Cl)=C1N LIBMRSQEMOANHL-VIFPVBQESA-N 0.000 description 1
• OYEKUVZUFASBGC-UHFFFAOYSA-N 2-chloro-9-[(4-methylphenyl)methyl]-n-phenylpurin-6-amine Chemical class C1=CC(C)=CC=C1CN1C2=NC(Cl)=NC(NC=3C=CC=CC=3)=C2N=C1 OYEKUVZUFASBGC-UHFFFAOYSA-N 0.000 description 1
• VBPSQGXFMBHYMD-UHFFFAOYSA-N 2-chloro-N-(1,3-dimethoxypropan-2-yl)-6-methyl-3-nitropyridin-4-amine Chemical compound COCC(COC)NC1=CC(C)=NC(Cl)=C1[N+]([O-])=O VBPSQGXFMBHYMD-UHFFFAOYSA-N 0.000 description 1
• MLIREBYILWEBDM-UHFFFAOYSA-M 2-cyanoacetate Chemical compound [O-]C(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-M 0.000 description 1
• 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
• MRYKPLCGITXZRW-UHFFFAOYSA-N 2-methyl-5-nitropyrimidine-4,6-diol Chemical compound CC1=NC(O)=C([N+]([O-])=O)C(=O)N1 MRYKPLCGITXZRW-UHFFFAOYSA-N 0.000 description 1
• XQRIJUCWNSYEEP-UHFFFAOYSA-N 2-methylsulfanyl-4-propan-2-ylaniline Chemical compound CSC1=CC(C(C)C)=CC=C1N XQRIJUCWNSYEEP-UHFFFAOYSA-N 0.000 description 1
• VXMBNYBJIZIYPS-UHFFFAOYSA-N 2-n-(2-bromo-4-propan-2-ylphenyl)-2-n-heptan-4-yl-6-methylpyridine-2,3,4-triamine Chemical compound N=1C(C)=CC(N)=C(N)C=1N(C(CCC)CCC)C1=CC=C(C(C)C)C=C1Br VXMBNYBJIZIYPS-UHFFFAOYSA-N 0.000 description 1
• HLTDBMHJSBSAOM-UHFFFAOYSA-N 2-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CC=N1 HLTDBMHJSBSAOM-UHFFFAOYSA-N 0.000 description 1
• PGGIJDAUBHJAFO-UHFFFAOYSA-N 2-nitropyrimidin-4-amine Chemical class NC1=CC=NC([N+]([O-])=O)=N1 PGGIJDAUBHJAFO-UHFFFAOYSA-N 0.000 description 1
• ZSYMMINAALNVSH-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridine Chemical class C1=NC=CC2=NNN=C21 ZSYMMINAALNVSH-UHFFFAOYSA-N 0.000 description 1
• APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
• YGQOMWFEBZYDEC-UHFFFAOYSA-N 3-(2-bromo-4-propan-2-ylphenyl)-7-chloro-5-methyltriazolo[4,5-d]pyrimidine Chemical compound BrC1=CC(C(C)C)=CC=C1N1C2=NC(C)=NC(Cl)=C2N=N1 YGQOMWFEBZYDEC-UHFFFAOYSA-N 0.000 description 1
• OJRQEHDWICWRRZ-IBGZPJMESA-N 3-(2-bromo-4-propan-2-ylphenyl)-n-[(2s)-1-methoxy-3-phenylpropan-2-yl]-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound C([C@@H](COC)NC=1C=2N=NN(C=2N=C(C)N=1)C=1C(=CC(=CC=1)C(C)C)Br)C1=CC=CC=C1 OJRQEHDWICWRRZ-IBGZPJMESA-N 0.000 description 1
• GSWYUZQBLVUEPH-UHFFFAOYSA-N 3-(azaniumylmethyl)benzoate Chemical compound NCC1=CC=CC(C(O)=O)=C1 GSWYUZQBLVUEPH-UHFFFAOYSA-N 0.000 description 1
• LHUFBNTWFMFYDN-UHFFFAOYSA-N 3-benzyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=NC=2C(N)=NC=NC=2N1CC1=CC=CC=C1 LHUFBNTWFMFYDN-UHFFFAOYSA-N 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• PCCSYAWZVABITQ-UHFFFAOYSA-N 3-nitro-n-phenylpyridin-2-amine Chemical compound [O-][N+](=O)C1=CC=CN=C1NC1=CC=CC=C1 PCCSYAWZVABITQ-UHFFFAOYSA-N 0.000 description 1
• FKRXXAMAHOGYNT-UHFFFAOYSA-N 4,6-dichloro-2-methylpyrimidin-5-amine Chemical compound CC1=NC(Cl)=C(N)C(Cl)=N1 FKRXXAMAHOGYNT-UHFFFAOYSA-N 0.000 description 1
• XJPZKYIHCLDXST-UHFFFAOYSA-N 4,6-dichloropyrimidine Chemical class ClC1=CC(Cl)=NC=N1 XJPZKYIHCLDXST-UHFFFAOYSA-N 0.000 description 1
• DSYUVNLLQJEARX-UHFFFAOYSA-N 4-(2-bromo-4-propan-2-ylphenyl)-6-chloro-2-methyl-2h-pyrimidine-1,5-diamine Chemical compound BrC1=CC(C(C)C)=CC=C1C1=NC(C)N(N)C(Cl)=C1N DSYUVNLLQJEARX-UHFFFAOYSA-N 0.000 description 1
• VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
• QLJCOJIISKCFSP-VIFPVBQESA-N 4-[[(2s)-1,4-dimethoxybutan-2-yl]amino]-6-methyl-3-nitro-1h-pyridin-2-one Chemical compound COCC[C@@H](COC)NC=1C=C(C)NC(=O)C=1[N+]([O-])=O QLJCOJIISKCFSP-VIFPVBQESA-N 0.000 description 1
• RGLDNSAKBSIEHN-UHFFFAOYSA-N 4-amino-3-nitro-1h-pyridin-2-one Chemical compound NC=1C=CNC(=O)C=1[N+]([O-])=O RGLDNSAKBSIEHN-UHFFFAOYSA-N 0.000 description 1
• PCHYYOCUCGCSBU-UHFFFAOYSA-N 4-bromo-2-methylaniline Chemical compound CC1=CC(Br)=CC=C1N PCHYYOCUCGCSBU-UHFFFAOYSA-N 0.000 description 1
• 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
• JYVASYONMUILLD-UHFFFAOYSA-N 4-chloro-1-heptan-4-yl-6-methyltriazolo[4,5-c]pyridine Chemical compound N1=C(C)C=C2N(C(CCC)CCC)N=NC2=C1Cl JYVASYONMUILLD-UHFFFAOYSA-N 0.000 description 1
• FTKBPJDVBRHPSV-UHFFFAOYSA-N 4-chloro-6-(1-methoxybutan-2-yl)-2-methyl-2h-pyrimidine-1,5-diamine Chemical compound COCC(CC)C1=C(N)C(Cl)=NC(C)N1N FTKBPJDVBRHPSV-UHFFFAOYSA-N 0.000 description 1
• IBTLEGRFPIHSRC-UHFFFAOYSA-N 4-chloro-6-(methoxymethyl)-2-N-(2-methylpropyl)pyridine-2,5-diamine Chemical compound CC(CNC1=NC(=C(C(=C1)Cl)N)COC)C IBTLEGRFPIHSRC-UHFFFAOYSA-N 0.000 description 1
• DFZFQTAWYXUIGJ-UHFFFAOYSA-N 4-chloro-6-methyl-1-pentan-3-yltriazolo[4,5-c]pyridine Chemical compound N1=C(C)C=C2N(C(CC)CC)N=NC2=C1Cl DFZFQTAWYXUIGJ-UHFFFAOYSA-N 0.000 description 1
• STABAPSYCQFWOK-UHFFFAOYSA-N 4-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=C(Cl)C=C1 STABAPSYCQFWOK-UHFFFAOYSA-N 0.000 description 1
• RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 description 1
• BPSGVKFIQZZFNH-UHFFFAOYSA-N 4-hydroxy-2-methyl-1h-pyrimidin-6-one Chemical compound CC1=NC(O)=CC(=O)N1 BPSGVKFIQZZFNH-UHFFFAOYSA-N 0.000 description 1
• KZAIJGIVAFZDDC-UHFFFAOYSA-N 5-methyl-3-pentan-3-yl-n-(2,4,6-trimethylphenyl)triazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(C(CC)CC)N=NC2=C1NC1=C(C)C=C(C)C=C1C KZAIJGIVAFZDDC-UHFFFAOYSA-N 0.000 description 1
• GGDJVADNPOLHER-UHFFFAOYSA-N 6-chloro-2-methyl-5-nitro-4-pentan-3-ylpyridin-3-amine Chemical compound ClC1=NC(=C(C(=C1[N+](=O)[O-])C(CC)CC)N)C GGDJVADNPOLHER-UHFFFAOYSA-N 0.000 description 1
• GWOHAZNYTZSMBW-UHFFFAOYSA-N 6-chloro-4-heptan-3-yl-2-methyl-5-nitropyridin-3-amine Chemical compound ClC1=NC(=C(C(=C1[N+](=O)[O-])C(CC)CCCC)N)C GWOHAZNYTZSMBW-UHFFFAOYSA-N 0.000 description 1
• CODGGPMWVJUUHI-UHFFFAOYSA-N 6-chloro-4-heptan-4-yl-2-methyl-5-nitropyridin-3-amine Chemical compound CCCC(CCC)C1=C(N)C(C)=NC(Cl)=C1[N+]([O-])=O CODGGPMWVJUUHI-UHFFFAOYSA-N 0.000 description 1
• KATOVCIUFMYWCH-UHFFFAOYSA-N 6-chloro-9-heptan-3-yl-2-methylpurine Chemical compound N1=C(C)N=C2N(C(CC)CCCC)C=NC2=C1Cl KATOVCIUFMYWCH-UHFFFAOYSA-N 0.000 description 1
• CBTGIMRRKCMJNS-UHFFFAOYSA-N 7-chloro-3-heptan-4-yl-5-methyltriazolo[4,5-d]pyrimidine Chemical compound N1=C(C)N=C2N(C(CCC)CCC)N=NC2=C1Cl CBTGIMRRKCMJNS-UHFFFAOYSA-N 0.000 description 1
• VTUXMBRRDAHBHG-UHFFFAOYSA-N 7-chloro-5-methyl-2h-triazolo[4,5-d]pyrimidine Chemical compound CC1=NC(Cl)=C2N=NNC2=N1 VTUXMBRRDAHBHG-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• MDOUSORGCMUMBO-UHFFFAOYSA-N 9-benzylpurine Chemical class C1=NC2=CN=CN=C2N1CC1=CC=CC=C1 MDOUSORGCMUMBO-UHFFFAOYSA-N 0.000 description 1
• ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000000103 Anorexia Nervosa Diseases 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• 229940110385 Benzodiazepine receptor antagonist Drugs 0.000 description 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
• BLKMNHLYUIWMGK-UHFFFAOYSA-N C(CC)N1C2=NC(=NC=C2N=C1)C Chemical compound C(CC)N1C2=NC(=NC=C2N=C1)C BLKMNHLYUIWMGK-UHFFFAOYSA-N 0.000 description 1
• VPYQXRRUZJVLKF-UHFFFAOYSA-N CC1(Cl)NC=C([N+]([O-])=O)C(Cl)=N1 Chemical compound CC1(Cl)NC=C([N+]([O-])=O)C(Cl)=N1 VPYQXRRUZJVLKF-UHFFFAOYSA-N 0.000 description 1
• GNDPRNUZOTXOIO-UHFFFAOYSA-N COCC(COC)C1=C(C(NC(=C1N)C)=O)[N+](=O)[O-] Chemical compound COCC(COC)C1=C(C(NC(=C1N)C)=O)[N+](=O)[O-] GNDPRNUZOTXOIO-UHFFFAOYSA-N 0.000 description 1
• 101100167280 Caenorhabditis elegans cin-4 gene Proteins 0.000 description 1
• CRZNCKMZSBBFSC-UHFFFAOYSA-N ClC1=NC(=C(C(=C1N)C(COC)COC)N)C Chemical compound ClC1=NC(=C(C(=C1N)C(COC)COC)N)C CRZNCKMZSBBFSC-UHFFFAOYSA-N 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 101710198652 Corticotropin-releasing factor receptor 1 Proteins 0.000 description 1
• 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
• OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 206010049119 Emotional distress Diseases 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• 102000004300 GABA-A Receptors Human genes 0.000 description 1
• 108090000839 GABA-A Receptors Proteins 0.000 description 1
• 101000933374 Gallus gallus Brain-specific homeobox/POU domain protein 3 Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 229910004373 HOAc Inorganic materials 0.000 description 1
• 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
• 101000878678 Homo sapiens Corticotropin-releasing factor receptor 1 Proteins 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 206010062767 Hypophysitis Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 229930194542 Keto Natural products 0.000 description 1
• QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• FITSZXQHLKGTBK-HNNXBMFYSA-N N-(2-chloro-4,6-dimethylphenyl)-1-[(2S)-1,4-dimethoxybutan-2-yl]-6-methyltriazolo[4,5-c]pyridin-4-amine Chemical compound N1=C(C)C=C2N([C@H](COC)CCOC)N=NC2=C1NC1=C(C)C=C(C)C=C1Cl FITSZXQHLKGTBK-HNNXBMFYSA-N 0.000 description 1
• IBQQHRPHIWGECW-UHFFFAOYSA-N N1=NC=2C(CC(O)CCC)=NC(C)=NC=2N1C1=CC=C(C(C)C)C=C1Br Chemical compound N1=NC=2C(CC(O)CCC)=NC(C)=NC=2N1C1=CC=C(C(C)C)C=C1Br IBQQHRPHIWGECW-UHFFFAOYSA-N 0.000 description 1
• ORMURJHMEFVXCS-UHFFFAOYSA-N NC=1C(=NC(=C(C1C(CC)CC)N)C)Cl Chemical compound NC=1C(=NC(=C(C1C(CC)CC)N)C)Cl ORMURJHMEFVXCS-UHFFFAOYSA-N 0.000 description 1
• JMJYEBDUMIDHIN-UHFFFAOYSA-N NC=1C(=NC(=C(C1C(CC)CCCC)N)C)Cl Chemical compound NC=1C(=NC(=C(C1C(CC)CCCC)N)C)Cl JMJYEBDUMIDHIN-UHFFFAOYSA-N 0.000 description 1
• VVFUWUMWKJZOFD-UHFFFAOYSA-N NC=1C(=NC(=C(C1C(CCC)CCC)N)C)Cl Chemical compound NC=1C(=NC(=C(C1C(CCC)CCC)N)C)Cl VVFUWUMWKJZOFD-UHFFFAOYSA-N 0.000 description 1
• URHKJGBDYPMXBJ-UHFFFAOYSA-N NC=1C(=NC(N(C1C(CC)CC)N)C)Cl Chemical compound NC=1C(=NC(N(C1C(CC)CC)N)C)Cl URHKJGBDYPMXBJ-UHFFFAOYSA-N 0.000 description 1
• WMFSYWIPLSLAMX-UHFFFAOYSA-N NC=1C(=NC(N(C1C(CC)CCCC)N)C)Cl Chemical compound NC=1C(=NC(N(C1C(CC)CCCC)N)C)Cl WMFSYWIPLSLAMX-UHFFFAOYSA-N 0.000 description 1
• TXBUIJFTBPUUDV-UHFFFAOYSA-N NC=1C(=NC(N(C1C(CCC)CCC)N)C)Cl Chemical compound NC=1C(=NC(N(C1C(CCC)CCC)N)C)Cl TXBUIJFTBPUUDV-UHFFFAOYSA-N 0.000 description 1
• 108090000189 Neuropeptides Proteins 0.000 description 1
• 102000003797 Neuropeptides Human genes 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 101000895537 Ovis aries Corticoliberin Proteins 0.000 description 1
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
• 229920002873 Polyethylenimine Polymers 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 108020005091 Replication Origin Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 208000013200 Stress disease Diseases 0.000 description 1
• GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
• 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• FBOJZEUQRGZYEG-UHFFFAOYSA-N [6-[butyl(propyl)amino]-2-methyl-5-nitropyrimidin-4-yl] 4-methylbenzenesulfonate Chemical compound CCCCN(CCC)C1=NC(C)=NC(OS(=O)(=O)C=2C=CC(C)=CC=2)=C1[N+]([O-])=O FBOJZEUQRGZYEG-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 150000003869 acetamides Chemical class 0.000 description 1
• TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 125000005076 adamantyloxycarbonyl group Chemical group C12(CC3CC(CC(C1)C3)C2)OC(=O)* 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
• 150000008041 alkali metal carbonates Chemical class 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 239000000935 antidepressant agent Substances 0.000 description 1
• 229940005513 antidepressants Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 239000003849 aromatic solvent Substances 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000002567 autonomic effect Effects 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• 239000000749 benzodiazepine receptor blocking agent Substances 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• 150000001602 bicycloalkyls Chemical group 0.000 description 1
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
• KFCUPNHUPHDVJC-UHFFFAOYSA-N bromine azide Chemical compound BrN=[N+]=[N-] KFCUPNHUPHDVJC-UHFFFAOYSA-N 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• RKSGFMRROMRUPP-UHFFFAOYSA-N butan-2-yloxymethanamine Chemical compound CCC(C)OCN RKSGFMRROMRUPP-UHFFFAOYSA-N 0.000 description 1
• 230000003491 cAMP production Effects 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• BJDCWCLMFKKGEE-CMDXXVQNSA-N chembl252518 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-CMDXXVQNSA-N 0.000 description 1
• 238000004296 chiral HPLC Methods 0.000 description 1
• ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 1
• 229960004782 chlordiazepoxide Drugs 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000010779 crude oil Substances 0.000 description 1
• DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 1
• 230000000994 depressogenic effect Effects 0.000 description 1
• RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 1
• 125000005265 dialkylamine group Chemical group 0.000 description 1
• 150000001983 dialkylethers Chemical class 0.000 description 1
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 208000010643 digestive system disease Diseases 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
• IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 230000001667 episodic effect Effects 0.000 description 1
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 210000005153 frontal cortex Anatomy 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 208000018685 gastrointestinal system disease Diseases 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 150000002357 guanidines Chemical class 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 230000002140 halogenating effect Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000001320 hippocampus Anatomy 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 150000004678 hydrides Chemical class 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• ZCQWOFVYLHDMMC-UHFFFAOYSA-O hydron;1,3-oxazole Chemical compound C1=COC=[NH+]1 ZCQWOFVYLHDMMC-UHFFFAOYSA-O 0.000 description 1
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
• 125000005350 hydroxycycloalkyl group Chemical group 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 210000003016 hypothalamus Anatomy 0.000 description 1
• 239000005457 ice water Substances 0.000 description 1
• 230000008799 immune stress Effects 0.000 description 1
• 230000000899 immune system response Effects 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000000468 ketone group Chemical group 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000012280 lithium aluminium hydride Substances 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 1
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
• MEVUPUNLVKELNV-JEDNCBNOSA-N methyl (2s)-2-amino-4-methylsulfanylbutanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CCSC MEVUPUNLVKELNV-JEDNCBNOSA-N 0.000 description 1
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• 229960002216 methylparaben Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• QYHOQZHNOOYRRM-UHFFFAOYSA-N n-(2-bromo-4-iodophenyl)-2-nitropyridin-3-amine Chemical compound [O-][N+](=O)C1=NC=CC=C1NC1=CC=C(I)C=C1Br QYHOQZHNOOYRRM-UHFFFAOYSA-N 0.000 description 1
• ZCFRVBBMXIKKNL-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-1-heptan-4-yl-6-methyltriazolo[4,5-c]pyridin-4-amine Chemical compound N1=C(C)C=C2N(C(CCC)CCC)N=NC2=C1NC1=CC=C(C(C)C)C=C1Br ZCFRVBBMXIKKNL-UHFFFAOYSA-N 0.000 description 1
• ZPKKWHQPRGDDLN-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-5-methyl-3-propyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N1=C(C)N=C2N(CCC)N=NC2=C1NC1=CC=C(C(C)C)C=C1Br ZPKKWHQPRGDDLN-UHFFFAOYSA-N 0.000 description 1
• KAELTIDLGRPTPY-UHFFFAOYSA-N n-(2-bromo-4-propan-2-ylphenyl)-n-ethyl-3-(3-methoxypropyl)-5-methyltriazolo[4,5-d]pyrimidin-7-amine Chemical compound N=1C(C)=NC=2N(CCCOC)N=NC=2C=1N(CC)C1=CC=C(C(C)C)C=C1Br KAELTIDLGRPTPY-UHFFFAOYSA-N 0.000 description 1
• 230000001722 neurochemical effect Effects 0.000 description 1
• 230000009251 neurologic dysfunction Effects 0.000 description 1
• 230000007658 neurological function Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• BKEVGGILGWUWSB-UHFFFAOYSA-N nonan-5-amine Chemical compound CCCCC(N)CCCC BKEVGGILGWUWSB-UHFFFAOYSA-N 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• AOCUKGFDRUSDQH-PIKKTMSISA-N ocrf Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)CC)[C@@H](C)O)C(C)C)C(C)O)C1=CNC=N1 AOCUKGFDRUSDQH-PIKKTMSISA-N 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 229940127240 opiate Drugs 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000002894 organic compounds Chemical class 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 239000007800 oxidant agent Substances 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
• 235000019629 palatability Nutrition 0.000 description 1
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 229950000964 pepstatin Drugs 0.000 description 1
• 108010091212 pepstatin Proteins 0.000 description 1
• FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 125000003884 phenylalkyl group Chemical group 0.000 description 1
• 229950007002 phosphocreatine Drugs 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 210000003635 pituitary gland Anatomy 0.000 description 1
• 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
• LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical class [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 1
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 229960003415 propylparaben Drugs 0.000 description 1
• 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 238000001525 receptor binding assay Methods 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
• CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 description 1
• 229940075931 sodium dithionate Drugs 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
• 229910052718 tin Inorganic materials 0.000 description 1
• 239000011135 tin Substances 0.000 description 1
• OVCXRBARSPBVMC-UHFFFAOYSA-N triazolopyridine Chemical compound C=1N2C(C(C)C)=NN=C2C=CC=1C=1OC=NC=1C1=CC=C(F)C=C1 OVCXRBARSPBVMC-UHFFFAOYSA-N 0.000 description 1
• 150000008523 triazolopyridines Chemical class 0.000 description 1
• 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
• ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
• 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
• PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
• UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 229910052721 tungsten Inorganic materials 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• MMSLSKDMIZOHRX-WYDAWZGFSA-N α-helical crf(9-41) Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(N)=O MMSLSKDMIZOHRX-WYDAWZGFSA-N 0.000 description 1